Form 4: United Therapeutics Director Nilda Mesa Sells 266 Shares
SEC Form 4
Director Nilda Mesa sold 266 shares of United Therapeutics Corp (UTHR) on June 25, 2024, at a price of $318.5784 per share.
Summary
- Nilda Mesa, a director of United Therapeutics Corporation, sold 266 shares of common stock on June 25, 2024.
- The sale price was $318.5784 per share.
- Following the transaction, Mesa directly owns 5,107 shares of United Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. A director selling a small number of shares is not inherently positive or negative.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and are closely watched by investors for signals about a company's prospects. While a sale doesn't necessarily indicate a negative outlook, it can sometimes influence investor sentiment.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder confidence, although the number of shares sold is relatively small.
Key Dates
| Date | Description |
|---|---|
| 06/25/2024 | Date of transaction: Nilda Mesa sold 266 shares of United Therapeutics Corp stock. |
| 06/26/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.